Connection

Andrew Kraft to Neoplasms, Experimental

Back to Details
This is a "connection" page, showing publications Andrew Kraft has written about Neoplasms, Experimental.
Andrew Kraft
Connection Strength
0.347
Neoplasms, Experimental
  1. Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response. Clin Cancer Res. 2019 02 01; 25(3):1036-1049.
    View in: PubMed
    Score: 0.154
  2. PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity. J Clin Invest. 2018 07 02; 128(7):2787-2801.
    View in: PubMed
    Score: 0.149
  3. Inhibitors of cyclin-dependent kinase and cancer. J Mol Med (Berl). 1995 Oct; 73(10):509-14.
    View in: PubMed
    Score: 0.031
  4. Decrease in cytosolic calcium/phospholipid-dependent protein kinase activity following phorbol ester treatment of EL4 thymoma cells. J Biol Chem. 1982 Nov 25; 257(22):13193-6.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.